Larvol Delta - Bacainn-Therapeutics-Presents-at-ECCO-21-Results-from-Phase-1-Study-that-Shows-BT051-an-Oral-LocallyActing-Inhibitor-of-Neutrophil-Trafcking-and-Activity-Is-Safe-and-WellTolerated-in-Healthy-Adults

BT051 - Bacainn Therap

https://www.businesswire.com/news/home/20210709005237/en/Bacainn-Therapeutics-Presents-at-ECCO-%E2%80%9821-Results-from-Phase-1-Study-that-Shows-BT051-an-Oral-Locally-Acting-Inhibitor-of-Neutrophil-Trafficking-and-Activity-Is-Safe-and-Well-Tolerated-in-Healthy-Adults

Jul 9, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next